Key facts
- This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
- 8 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Nov 2026, 21:57.
Peter Anevski - 05 Nov 2026 Form 4 Insider Report for Progyny, Inc. (PGNY)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- PGNY
- Reported as of
- 05 Nov 2026
- Net transaction value
- -$6,182,254
- SEC form
- 4
- Accepted by SEC
- 09 Nov 2026, 21:57:19 UTC
- Prior SEC filing
- 08 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Livingston, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Peter Anevski filed Form 4 for Progyny, Inc. (PGNY) on 09 Nov 2026.
Change
- Previous filing in this sequence was filed on 08 Sep 2026.
- Current net transaction value: -$6,182,254.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001576147
Primary reporting owner
Anevski Peter
- Relationship
- CHIEF EXECUTIVE OFFICER, Director
- Address
- C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK
- Signature
- /s/ Mark Livingston, Attorney-in-Fact
- Signature date
- 09 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGNY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,400
- Change %
- +0.42%
- Price
- $0.9100*
- Shares after
- 809,511
- Date
- 05 Nov 2026
- Ownership
- Direct
PGNY
transaction
Common Stock
Sale
- Transaction value
- -$119,774
- Shares
- -3,400
- Change %
- -0.42%
- Price
- $35.23
- Shares after
- 806,111
- Date
- 05 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
PGNY
transaction
Common Stock
Sale
- Transaction value
- -$299,639
- Shares
- -8,539
- Change %
- -1.1%
- Price
- $35.09
- Shares after
- 797,572
- Date
- 05 Nov 2026
- Ownership
- Direct
- Footnotes
- F2, F3
PGNY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +126,204
- Change %
- +16%
- Price
- $0.9100*
- Shares after
- 923,776
- Date
- 09 Nov 2026
- Ownership
- Direct
PGNY
transaction
Common Stock
Sale
- Transaction value
- -$4,508,726
- Shares
- -126,204
- Change %
- -14%
- Price
- $35.73
- Shares after
- 797,572
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F4
PGNY
transaction
Common Stock
Sale
- Transaction value
- -$1,254,115
- Shares
- -35,104
- Change %
- -4.4%
- Price
- $35.73
- Shares after
- 762,468
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F2, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGNY
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -3,400
- Change %
- -0.72%
- Price
- $0.000000*
- Shares after
- 468,707
- Date
- 05 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,400
- Exercise price
- $0.9100
- Footnotes
- F5
PGNY
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -126,204
- Change %
- -27%
- Price
- $0.000000*
- Shares after
- 342,503
- Date
- 09 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 126,204
- Exercise price
- $0.9100
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 2, 2026.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
Footnote F5
These options are fully vested and exercisable.